Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andy Pasternak currently holds 45,000 shares of Horizon Therapeutics Public Ltd Co (HZNP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andy Pasternak has been a net seller of HZNP stock. They have purchased $0 and sold $13.9M worth of shares.
Andy Pasternak's most recent insider trade was on Jun 24, 2026, when they sold 45,000 shares at $0.00 per share.
Andy Pasternak serves as Executive at Horizon Therapeutics Public Ltd Co (HZNP). They have executed 42 insider transactions totaling $13.9M over their tenure at the company.
Andy Pasternak holds the position of Executive at Horizon Therapeutics Public Ltd Co, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Andy Pasternak has shown a selling trading pattern, with $0 in total purchases and $13.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andy Pasternak was on Oct 6, 2023, when they sold $6.6M worth of HZNP shares. This transaction involved 56,338 shares at $116.50 per share.
Andy Pasternak currently owns 45,000 shares of Horizon Therapeutics Public Ltd Co (HZNP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andy Pasternak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andy Pasternak has 42 Form 4 filings on record as an insider at Horizon Therapeutics Public Ltd Co.
Set alerts for Andy Pasternak and 40,000+ other insiders.